Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome

Objective: To investigate the relationship between ovarian androgen excess and impaired growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis in nonobese women with polycystic ovary syndrome (PCOS). Design: A prospective, controlled clinical study. Setting: Reproductive Endocrine Unit, Department of Obstetrics and Gynecology, Jinling Hospital, Nanjing University School of Clinical Medicine. Patient(s): Six patients with PCOS with both clomiphene resistance and gonadotropin hyperreponsiveness and six controls with regular cycles, matched fur age and body mass index (BMI). Intervention(s): Bilateral ovarian wedge resection (OWR) was performed to induce ovulation surgically for these refractory women with PCOS. A GH stimulation test with oral L-dopa was arranged for controls and for patients with PCOS before and again 6 months later after OWR. Main Outcome Measure(s): Plasma CII, IGF-1, FSH, LII, testosterone, androstenedione, estradiol, progesterone, prolactin, insulin, and glucose. Result(s): Basal levels and areas under the response curve of GH and GH-IGF-1 ratio to L-dopa were significantly lower in patients with PCOS before surgery than those of controls. The OWR in patients with PCOS obviously reduced their androstenedione and testosterone levels and insulin-glucose ratios, and increased the GH and GH-IGF-1 responses to L-dopa. Conclusion(s): Impaired somatotrophic axis caused by a defect in central dopaminergic activity may be responsible for seven anovulation in these women with PCOS, which could be reversed by removing excessive androgens with OWR.